stock
TRAX · First Tracks Biotherapeutics, Inc.
What First Tracks Biotherapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live TRAX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on TRAX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 35,730,843 as of 2026-08-07 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- —
- ROA
- —
Health
- Current ratio
- 14.3x
- Debt/equity
- —
Deep value
- NCAV
- —
- NCAV per share
- —
- Price/NCAV
- Locked
- NNWC
- —
- NNWC per share
- —
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to —; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue (not reported by this company) | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$34.94M | -$33.37M | 10-Q filed 2026-08-12 |
| 2026-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$52.81M | -$50.48M | 10-Q filed 2026-08-12 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$45.90M | -$42.45M | 10-Q filed 2026-08-12 |
| 2025-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$51.28M | -$47.20M | 10-Q filed 2026-08-12 Assembled from more than one filing; the filing above is only the newest of them. |
- Assets
- $183.14M
- Equity
- $168.80M
Balance as of 2026-06-30.
Ten years
No annual results reported by SEC for this filer.
Company filings
3 offering filings in 12 months
events
Results
ResultsAug 128-KMaterial agreement
Material agreementJun 228-KResults
ResultsMay 148-KMaterial agreement, Acquisition or sale completed, Unregistered share sale, Shareholder rights changed, Change in control, Executive or director change, Bylaws or fiscal year change, Other event
Material agreementAcquisition or sale completedUnregistered share saleShareholder rights changedChange in controlExecutive or director changeBylaws or fiscal year changeOther eventApr 208-KRegulation FD disclosure
Regulation FD disclosureApr 28-K
5% owners ()
TCG Crossover GP II, LLC
Passive stake
Sirenia Capital Management LP
Passive stake
Affinity Asset Advisors, LLC
Passive stake
FMR LLC
Passive stake
BlackRock, Inc.
Passive stake
Insiders, politicians and funds
Insider trades, last 90 days
Ware J. Anthony
Director
Sale$1,758,145Sep 4, 4:25 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
News
Stories that named TRAX, and the market events around them.
Sign in to see thisBoard
The TRAX board could not be loaded.
Retry the TRAX boardnakagai
Signals on TRAX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the TRAX board